XORTX Therapeutics Inc. (XRTX.V)
CAD 1.62
(-7.43%)
CAD 1.62
(-7.43%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -8.88 Million | -8.81 Million | -4.75 Million | -728.4 Thousand | -249.58 Thousand | -1.55 Million |
| Net Income | -2.91 Million | -6.98 Million | -1.29 Million | -1.28 Million | -629.57 Thousand | -3.77 Million |
| Depreciation & Amortization | 188.54 Thousand | 55.45 Thousand | 14.02 Thousand | 20.43 Thousand | 19.9 Thousand | 19.31 Thousand |
| Deferred income taxes | - | -3.8 Million | -2.84 Million | -29.72 Thousand | 34.06 Thousand | -46.92 Thousand |
| Stock-based compensation | 120.98 Thousand | 487.94 Thousand | 396.42 Thousand | 230.12 Thousand | 26.31 Thousand | 275.09 Thousand |
| Change in working capital | -1.39 Million | 1.44 Million | -1.07 Million | 362.21 Thousand | 298.07 Thousand | -674.01 Thousand |
| Other non-cash items | -4.42 Million | 3703.92 | 58.82 Thousand | -90.16 Thousand | 1638.00 | 2.64 Million |
| Investing Cash Flow | -62.57 Thousand | -44.22 Thousand | -31.22 Thousand | -14.35 Thousand | -7037.00 | -154.8 Thousand |
| Investments in PPE | -62.57 Thousand | -44.22 Thousand | -31.22 Thousand | -14.35 Thousand | -7037.00 | -41.07 Thousand |
| Acquisitions | - | - | - | - | - | -280.95 Thousand |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -42.05 Thousand | - | - | - | - | 167.22 Thousand |
| Financing Cash Flow | -487.29 Thousand | 4.73 Million | 19.18 Million | 855.4 Thousand | 55.21 Thousand | 1.9 Million |
| Debt repayment | -66.08 Thousand | -40.61 Thousand | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | -398.09 Thousand | 5.05 Million | 17.88 Million | 900 Thousand | 70 Thousand | 1.95 Million |
| Other Financing Activities | -295.25 Thousand | -272.26 Thousand | 1.3 Million | -44.59 Thousand | -14.78 Thousand | -49.12 Thousand |
| Accounts receivables | 28.39 Thousand | -43.61 Thousand | -29.16 Thousand | -42.99 Thousand | 14.78 Thousand | -20.06 Thousand |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | -1.41 Million | 1.49 Million | -1.05 Million | 405.21 Thousand | 283.28 Thousand | -653.95 Thousand |
| Cash at beginning of period | 14.12 Million | 13.88 Million | 134.32 Thousand | 58.61 Thousand | 260.01 Thousand | 61.93 Thousand |
| Cash at end of period | 4.54 Million | 10.4 Million | 14.78 Million | 171.27 Thousand | 58.61 Thousand | 260.01 Thousand |
| Capital Expenditure | -62.57 Thousand | -44.22 Thousand | -31.22 Thousand | -14.35 Thousand | -7037.00 | -41.07 Thousand |
| Effect of forex changes on cash | 4041.00 | 642.23 Thousand | 255.47 Thousand | - | - | - |
| Net cash flow / Change in cash | -9.57 Million | -3.48 Million | 14.65 Million | 112.65 Thousand | -201.4 Thousand | 198.08 Thousand |
| Free Cash Flow | -8.94 Million | -8.86 Million | -4.78 Million | -742.75 Thousand | -256.61 Thousand | -1.59 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 170.06 Thousand | -3.01 Million | -2.91 Million | 2.69 Million | -1.33 Million | -1.69 Million |
| Depreciation & Amortization | 33.04 Thousand | 32.13 Thousand | 188.54 Thousand | 24.36 Thousand | 16.46 Thousand | 32.02 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | 44.03 Thousand | 53.13 Thousand | 120.98 Thousand | 28.81 Thousand | 21.85 Thousand | 30.76 Thousand |
| Change in working capital | 659.18 Thousand | -326.86 Thousand | -1.39 Million | -412.2 Thousand | 222.16 Thousand | -95.51 Thousand |
| Other non-cash items | -1.64 Million | 224.48 Thousand | -4.42 Million | -4.86 Million | 2161.00 | -5959.00 |
| Investing Cash Flow | -9084.00 | -2623.00 | -62.57 Thousand | -9795.00 | -7299.00 | -9538.00 |
| Investments in PPE | -9084.00 | -2623.00 | -62.57 Thousand | -9795.00 | -7299.00 | -9538.00 |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -9084.00 | - | - | - | - | - |
| Financing Cash Flow | -8857.00 | 1.7 Million | -487.29 Thousand | -312.25 Thousand | -16.67 Thousand | -8762.00 |
| Debt repayment | -8857.00 | -15.94 Thousand | -66.08 Thousand | -17 Thousand | -16.67 Thousand | -14.97 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 2 Million | -398.09 Thousand | -398.49 Thousand | -0.27 | 8397.94 |
| Other Financing Activities | - | -297.6 Thousand | -295.25 Thousand | - | 0.27 | -2187.94 |
| Accounts receivables | 8076.00 | 29.82 Thousand | 28.39 Thousand | 7530.00 | -37.82 Thousand | 6007.00 |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 651.1 Thousand | -481.03 Thousand | -1.41 Million | -568.27 Thousand | 259.99 Thousand | -101.51 Thousand |
| Cash at beginning of period | 3.83 Million | 3.44 Million | 14.12 Million | 5.06 Million | 6.16 Million | 7.9 Million |
| Cash at end of period | 3.07 Million | 3.83 Million | 4.54 Million | 3.44 Million | 5.06 Million | 6.16 Million |
| Capital Expenditure | -9084.00 | -2623.00 | -62.57 Thousand | -9795.00 | -7299.00 | -9538.00 |
| Effect of forex changes on cash | -2490.00 | -9317.00 | 4041.00 | -1453.00 | -246.00 | 4580.00 |
| Net cash flow / Change in cash | -756.96 Thousand | 387.77 Thousand | -9.57 Million | -1.62 Million | -1.09 Million | -1.74 Million |
| Free Cash Flow | -745.62 Thousand | -1.3 Million | -8.94 Million | -1.3 Million | -1.07 Million | -1.74 Million |
NCTW
FSV
QBY
NEM
002116
BKQNF